ReviewFrontiers in public health2026
Emerging information technologies across the autism service and prevention continuum: a narrative review of screening, diagnosis, intervention, and health equity.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autism spectrum disorder (ASD) is a major global public-health concern, yet timely identification and support remain difficult to access for many families, especially in rural, low-resource, and otherwise underserved settings. Emerging information technologies have been proposed as tools for narrowing this service gap. These include artificial intelligence (AI), wearable sensors, and the Internet of Things, mobile health applications and digital therapeutics, telehealth, immersive virtual and augmented reality, social robotics, and large language models. This narrative review organizes the evidence across an autism service and prevention continuum: upstream risk awareness and health education, early screening and diagnosis, and intervention, management, and long-term support. We use this continuum strictly as a public-health service-organization framework, not to imply preventing the birth or existence of autistic individuals, consistent with a neurodiversity-affirming perspective. Across each stage, we apply a health-equity lens centered on reach, affordability, scalability, health-system integration, and equity of performance. We summarize current applications, appraise recurring limitations, and synthesize cross-cutting issues of equity, data governance, ethics, neurodiversity, and implementation. Recurring limitations include small and heterogeneous studies, dataset bias, weak external validation, short follow-up, and uneven regulatory maturity. Emerging information technologies show genuine promise as complements to conventional autism services, particularly where specialist resources are scarce. Realizing population-level benefit will require equity-centered design, validation in diverse and low-resource settings, larger and longer trials, interoperable standards, and meaningful involvement of autistic people and their families.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.